{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:55:23Z","timestamp":1790686523449,"version":"4.1.0"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s10067-021-05968-1","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T04:02:47Z","timestamp":1634788967000},"page":"617-634","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Biomarkers in axial spondyloarthritis and low back pain: a comprehensive review"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5950-0913","authenticated-orcid":false,"given":"John D.","family":"Reveille","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,21]]},"reference":[{"issue":"6","key":"5968_CR1","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s10067-015-2949-3","volume":"34","author":"JD Reveille","year":"2015","unstructured":"Reveille JD (2015) Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis. Clin Rheumatol 34(6):1009\u20131018. https:\/\/doi.org\/10.1007\/s10067-015-2949-3","journal-title":"Clin Rheumatol"},{"issue":"10","key":"5968_CR2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3389\/fimmu.2019.00305","volume":"7","author":"WP Maksymowych","year":"2019","unstructured":"Maksymowych WP (2019) Biomarkers for diagnosis of axial spondyloarthritis, disease activity, prognosis, and prediction of response to therapy. Front Immunol 7(10):305. https:\/\/doi.org\/10.3389\/fimmu.2019.00305","journal-title":"Front Immunol"},{"issue":"8","key":"5968_CR3","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41584-020-0450-0","volume":"16","author":"MA Brown","year":"2020","unstructured":"Brown MA, Li Z, Cao KL (2020) Biomarker development for axial spondyloarthritis. Nat Rev Rheumatol 16(8):448\u2013463. https:\/\/doi.org\/10.1038\/s41584-020-0450-0","journal-title":"Nat Rev Rheumatol"},{"key":"5968_CR4","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777\u2013783","journal-title":"Ann Rheum Dis"},{"key":"5968_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/ard.2008.094870","volume":"68","author":"C Lukas","year":"2009","unstructured":"Lukas C, Landew\u00e9 R, Sieper J, Dougados M, Davis J, Braun J et al (2009) Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 68:18\u201324. https:\/\/doi.org\/10.1136\/ard.2008.094870","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"5968_CR6","first-page":"980","volume":"26","author":"A Spoorenberg","year":"1999","unstructured":"Spoorenberg A, van der Heijde D, de Klerk E, Dougados M, de Vlam K, Mielants H et al (1999) Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26(4):980\u2013984","journal-title":"J Rheumatol"},{"issue":"4","key":"5968_CR7","first-page":"966","volume":"26","author":"J Ruof","year":"1999","unstructured":"Ruof J, Stucki G (1999) Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review. J Rheumatol 26(4):966\u2013970","journal-title":"J Rheumatol"},{"issue":"1","key":"5968_CR8","doi-asserted-by":"publisher","first-page":"e000319","DOI":"10.1136\/rmdopen-2016-000319","volume":"3","author":"MC Turina","year":"2017","unstructured":"Turina MC, Yeremenko N, van Gaalen F, van Oosterhout M, Berg IJ, Ramonda R et al (2017) Serum inflammatory biomarkers fail to identify early axial spondyloarthritis: results from the SpondyloArthritis Caught Early (SPACE) cohort. RMD Open 3(1):e000319. https:\/\/doi.org\/10.1136\/rmdopen-2016-000319","journal-title":"RMD Open"},{"issue":"11","key":"5968_CR9","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1016\/j.spinee.2018.06.349","volume":"18","author":"R van den Berg","year":"2018","unstructured":"van den Berg R, Jongbloed EM, de Schepper EIT, Bierma-Zeinstra SMA, Koes BW, Luijsterburg PAJ et al (2018) The association between pro-inflammatory biomarkers and nonspecific low back pain: a systematic review. Spine J 18(11):2140\u20132151. https:\/\/doi.org\/10.1016\/j.spinee.2018.06.349","journal-title":"Spine J"},{"issue":"1","key":"5968_CR10","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12891-020-3154-3","volume":"21","author":"P Morris","year":"2020","unstructured":"Morris P, Ali K, Merritt M, Pelletier J, Morris MLG, P, et al (2020) A systematic review of the role of inflammatory biomarkers in acute, subacute and chronic non-specific low back pain. BMC Musculoskelet Disord 21(1):142. https:\/\/doi.org\/10.1186\/s12891-020-3154-3","journal-title":"BMC Musculoskelet Disord"},{"issue":"5","key":"5968_CR11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/AJP.0000000000000810","volume":"36","author":"YZ Lim","year":"2020","unstructured":"Lim YZ, Wang Y, Cicuttini FM, Hughes HJ, Chou L, Urquhart DM et al (2020) Association between inflammatory biomarkers and nonspecific low back pain: a systematic review. Clin J Pain 36(5):379\u2013389. https:\/\/doi.org\/10.1097\/AJP.0000000000000810","journal-title":"Clin J Pain"},{"issue":"2","key":"5968_CR12","doi-asserted-by":"publisher","first-page":"e001108","DOI":"10.1136\/rmdopen-2019-00110","volume":"5","author":"C L\u00f3pez-Medina","year":"2019","unstructured":"L\u00f3pez-Medina C, Ramiro S, van der Heijde D, Sieper J, Dougados M, Molto A (2019) Characteristics and burden of disease in patients with radiographic and non-radiographic axial spondyloarthritis: a comparison by systematic literature review and meta-analysis. RMD Open 5(2):e001108. https:\/\/doi.org\/10.1136\/rmdopen-2019-00110","journal-title":"RMD Open"},{"issue":"1","key":"5968_CR13","doi-asserted-by":"publisher","first-page":"13728","DOI":"10.1038\/s41598-018-32199-3.-","volume":"8e","author":"F Genre","year":"2018","unstructured":"Genre F, Rueda-Gotor J, Remuzgo-Mart\u00ednez S, Corrales A, Mijares V, Exp\u00f3sito R et al (2018) Association of circulating calprotectin with lipid profile in axial spondyloarthritis. Sci Rep 8e(1):13728. https:\/\/doi.org\/10.1038\/s41598-018-32199-3.-","journal-title":"Sci Rep"},{"issue":"3","key":"5968_CR14","first-page":"358","volume":"37","author":"AS Siebuhr","year":"2019","unstructured":"Siebuhr AS, Hu\u0161akov\u00e1 M, Forejtov\u00e1 S, Zegzulkov\u00e1 K, Tom\u010dik M, Urbanov\u00e1 M et al (2019) Metabolites of C-reactive protein and vimentin are associated with disease activity of axial spondyloarthritis. Clin Exp Rheumatol 37(3):358\u2013366","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"5968_CR15","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1177\/0300060517708693","volume":"45","author":"L Gonzalez-Lopez","year":"2017","unstructured":"Gonzalez-Lopez L, Fajardo-Robledo NS, Miriam Salda\u00f1a-Cruz A, Moreno-Sandoval IV, Bonilla-Lara D, Zavaleta-Mu\u00f1iz S et al (2017) Association of adipokines, interleukin-6, and tumor necrosis factor-\u03b1 concentrations with clinical characteristics and presence of spinal syndesmophytes in patients with ankylosing spondylitis: A cross-sectional study. J Int Med Res 45(3):1024\u20131035. https:\/\/doi.org\/10.1177\/0300060517708693","journal-title":"J Int Med Res"},{"issue":"1","key":"5968_CR16","doi-asserted-by":"publisher","first-page":"7731","DOI":"10.1038\/s41598-018-25722-z","volume":"8","author":"N Rosine","year":"2018","unstructured":"Rosine N, Etcheto A, Hendel-Chavez H, Seror R, Briot K, Molto A et al (2018) Increase in IL-31 serum levels is associated with reduced structural damage in early axial spondyloarthritis. Sci Rep 8(1):7731. https:\/\/doi.org\/10.1038\/s41598-018-25722-z","journal-title":"Sci Rep"},{"issue":"3","key":"5968_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s40744-019-0161-AB","volume":"6","author":"JC Nossent","year":"2019","unstructured":"Nossent JC, Sagen-Johnsen S, Bakland G (2019) Disease activity and patient-reported health measures in relation to cytokine levels in ankylosing spondylitis. Rheumatol Ther 6(3):369\u2013378. https:\/\/doi.org\/10.1007\/s40744-019-0161-AB","journal-title":"Rheumatol Ther"},{"key":"5968_CR18","doi-asserted-by":"publisher","unstructured":"Li Z, Wu X, Leo PL, deGuzman E, Akkoc N, Breban M, et al (2021) Polygenic Risk Scores have high diagnostic capacity in ankylosing spondylitis. Li Ann Rheum Dis. 80(9):1168\u20131174. https:\/\/doi.org\/10.1136\/annrheumdis-2020-219446. Online ahead of print","DOI":"10.1136\/annrheumdis-2020-219446"},{"issue":"2","key":"5968_CR19","first-page":"229","volume":"35","author":"GP Thomas","year":"2017","unstructured":"Thomas GP, Willner D, Robinson PC, Cortes A, Duan R, Rudwaleit M et al (2017) Genetic diagnostic profiling in axial spondyloarthritis: a real world study. Clin Exp Rheumatol 35(2):229\u2013233","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"5968_CR20","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1093\/rheumatology\/kez594","volume":"59","author":"Z Liu","year":"2020","unstructured":"Liu Z, Huang F, Luo G, Wang Y, Du R, Sun W et al (2020 May 1) (2020) miR-214 stimulated by IL-17A regulates bone loss in patients with ankylosing spondylitis. Rheumatology (Oxford) 59(5):1159\u20131169. https:\/\/doi.org\/10.1093\/rheumatology\/kez594","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"5968_CR21","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s13075-016-1200-1","volume":"18","author":"RD Inman","year":"2016","unstructured":"Inman RD, Baraliakos X, Hermann KA, Braun J, Deodhar A, van der Heijde D et al (2016) Serum biomarkers and changes in clinical\/MRI evidence of golimumab-treated patients with ankylosing spondylitis: results of the randomized, placebo-controlled GO-RAISE study. Arthritis Res Ther 18(1):304. https:\/\/doi.org\/10.1186\/s13075-016-1200-1","journal-title":"Arthritis Res Ther"},{"key":"5968_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.arcmed.2016.03.001","volume":"47","author":"YJ Mei","year":"2016","unstructured":"Mei YJ, Wang P, Chen LJ, Li ZJ (2016) Plasma\/serum leptin levels in patients with ankylosing spondylitis: a systematic review and meta-analysis. Arch Med Res 47:111\u2013117. https:\/\/doi.org\/10.1016\/j.arcmed.2016.03.001","journal-title":"Arch Med Res"},{"issue":"1","key":"5968_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13075-020-02149-4","volume":"22","author":"A Lin","year":"2020","unstructured":"Lin A, Inman RD, Streutker CJ, Zhang Z, Pritzker KPH, Tsui HW, Tsui FWL (2020) Lipocalin 2 links inflammation and ankyloses in the clinical overlap of inflammatory bowel disease (IBD) and ankylosing spondylitis (AS). Arthritis Res Ther 22(1):51. https:\/\/doi.org\/10.1186\/s13075-020-02149-4","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"5968_CR24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13075-017-1350-9","volume":"19","author":"A Hartl","year":"2017","unstructured":"Hartl A, Sieper J, Syrbe U, Listing J, Hermann KG, Rudwaleit M, Poddubnyy D (2017) Serum levels of leptin and high molecular weight adiponectin are inversely associated with radiographic spinal progression in patients with ankylosing spondylitis: results from the ENRADAS trial. Arthritis Res Ther 19(1):140. https:\/\/doi.org\/10.1186\/s13075-017-1350-9","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"5968_CR25","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00296-019-04301-z","volume":"39","author":"H Hulejov\u00e1","year":"2019","unstructured":"Hulejov\u00e1 H, Krop\u00e1\u010dkov\u00e1 T, Bubov\u00e1 K, Kry\u0161t\u016ffkov\u00e1 O, Filkov\u00e1 M, Mann H et al (2019) Serum visfatin levels in patients with axial spondyloarthritis and their relationship to disease activity and spinal radiographic damage: a cross-sectional study. Rheumatol Int 39(6):1037\u20131043. https:\/\/doi.org\/10.1007\/s00296-019-04301-z","journal-title":"Rheumatol Int"},{"issue":"3","key":"5968_CR26","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/BSD.0b013e3181e15cc8","volume":"24","author":"C Romero-Sanchez","year":"2011","unstructured":"Romero-Sanchez C, Tsou HK, Jan MS, Wong RH, Chang IC, Londo\u00f1o J, a, (2011) Serum monocyte chemotactic protein-1 concentrations distinguish patients with ankylosing spondylitis from patients with mechanical low back pain. J Spinal Disord Tech 24(3):202\u2013207. https:\/\/doi.org\/10.1097\/BSD.0b013e3181e15cc8","journal-title":"J Spinal Disord Tech"},{"issue":"4","key":"5968_CR27","doi-asserted-by":"publisher","first-page":"17068","DOI":"10.4238\/2015.December.16.7","volume":"14","author":"JW Gao","year":"2015","unstructured":"Gao JW, Zhang KF, Lu JS, Su T (2015) Serum matrix metalloproteinases-3 levels in patients with ankylosing spondylitis. Genet Mol Res 14(4):17068\u201317078. https:\/\/doi.org\/10.4238\/2015.December.16.7","journal-title":"Genet Mol Res"},{"issue":"4","key":"5968_CR28","doi-asserted-by":"publisher","first-page":"589","DOI":"10.7754\/clin.lab.2015.150801","volume":"62","author":"L Muntean","year":"2016","unstructured":"Muntean L, Lungu A, Gheorghe SR, Valeanu M, Craciun AM, Felea I et al (2016) Elevated serum levels of sclerostin are associated with high disease activity and functional impairment in patients with axial spondyloarthritis. Clin Lab 62(4):589\u2013597. https:\/\/doi.org\/10.7754\/clin.lab.2015.150801","journal-title":"Clin Lab"},{"key":"5968_CR29","first-page":"1044","volume":"37","author":"FM Perrotta","year":"2019","unstructured":"Perrotta FM, Scriffignano S, Lubrano E (2019) Assessment of bone morphogenic protein 2 and interleukin-17A in patients with axial spondyloarthritis and their potential role in the new bone formation: a cross-sectional study. Clin Exp Rheumatol 37:1044\u20131047","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"5968_CR30","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1111\/1756-185X.13997","volume":"23","author":"DS Saif","year":"2020","unstructured":"Saif DS, El Tabl MA, Afifi N, Abdallah MS, El Hefnawy SM, Hassanein SA (2020) Interleukin-17A biomarker as a predictor for detection of early axial spondyloarthritis changes in patients with psoriasis. Int J Rheum Dis 23(12):1664\u20131669. https:\/\/doi.org\/10.1111\/1756-185X.13997","journal-title":"Int J Rheum Dis"},{"issue":"6","key":"5968_CR31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3389\/fmed.2019.00177","volume":"7","author":"M Lorenzin","year":"2019","unstructured":"Lorenzin M, Ortolan A, Felicetti M, Favero M, Vio S, Zaninotto M et al (2019) Serological biomarkers in early axial spondyloarthritis during 24-months follow up (Italian Arm of Space Study). Front Med (Lausanne) 7(6):177. https:\/\/doi.org\/10.3389\/fmed.2019.00177","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"5968_CR32","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00198-018-4721-4","volume":"30","author":"L Torres","year":"2019","unstructured":"Torres L, Klingberg E, Nurkkala M, Carlsten H, Forsblad-d\u2019Elia H (2019) Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis. Osteoporos Int 30(2):441\u2013449. https:\/\/doi.org\/10.1007\/s00198-018-4721-4","journal-title":"Osteoporos Int"},{"issue":"4","key":"5968_CR33","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1007\/s00586-020-06713-z","volume":"30","author":"J Karppinen","year":"2021","unstructured":"Karppinen J, Koivisto K, Ketola J, Haapea M, Paananen M, Herzig KH et al (2021) Serum biomarkers for Modic changes in patients with chronic low back pain. Eur Spine J 30(4):1018\u20131027. https:\/\/doi.org\/10.1007\/s00586-020-06713-z","journal-title":"Eur Spine J"},{"key":"5968_CR34","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.intimp.2017.09.029","volume":"52","author":"J Yang","year":"2017","unstructured":"Yang J, Zhang X, Ma Y, Wu M, Hu X, Han R et al (2017) Serum levels of leptin, adiponectin and resistin in patients with ankylosing spondylitis: a systematic review and meta-analysis. Int Immunopharmacol 52:310\u2013317. https:\/\/doi.org\/10.1016\/j.intimp.2017.09.029","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"5968_CR35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13075-021-02521-y","volume":"23","author":"FWL Tsui","year":"2021","unstructured":"Tsui FWL, Lin A, Sari I, Zhang Z, Tsui HW, Inman R (2021) Serial Lipocalin 2 and Oncostatin M levels reflect inflammation status and treatment response in axial spondyloarthritis. Arthritis Res Ther 23(1):141. https:\/\/doi.org\/10.1186\/s13075-021-02521-y","journal-title":"Arthritis Res Ther"},{"issue":"33","key":"5968_CR36","doi-asserted-by":"publisher","first-page":"e7854","DOI":"10.1097\/MD.0000000000007854","volume":"96","author":"JH Park","year":"2017","unstructured":"Park JH, Lee SG, Jeon YK, Park EK, Suh YS, Kim HO (2017) Relationship between serum adipokine levels and radiographic progression in patients with ankylosing spondylitis: a preliminary 2-year longitudinal study. Medicine (Baltimore) 96(33):e7854. https:\/\/doi.org\/10.1097\/MD.0000000000007854","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"5968_CR37","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1007\/s10067-017-3624-7","volume":"36","author":"D He","year":"2017","unstructured":"He D, Zhu Q, Zhou Q, Qi Q, Sun H, Zachariah LM et al (2017) Correlation of serum MMP3 and other biomarkers with clinical outcomes in patients with ankylosing spondylitis: a pilot study. Clin Rheumatol 36(8):1819\u20131826. https:\/\/doi.org\/10.1007\/s10067-017-3624-7","journal-title":"Clin Rheumatol"},{"issue":"5","key":"5968_CR38","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1080\/14397595.2018.1519103","volume":"29","author":"H Hu","year":"2019","unstructured":"Hu H, Du F, Zhang S, Zhang W (2019) Serum calprotectin correlates with risk and disease severity of ankylosing spondylitis and its change during first month might predict favorable response to treatment. Mod Rheumatol 29(5):836\u2013842. https:\/\/doi.org\/10.1080\/14397595.2018.1519103","journal-title":"Mod Rheumatol"},{"issue":"12","key":"5968_CR39","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1007\/s10067-016-3448-x","volume":"35","author":"L Gupta","year":"2016","unstructured":"Gupta L, Bhattacharya S, Agarwal V, Aggarwal A (2016) Elevated levels of serum MRP8\/14 in ankylosing spondylitis: associated with peripheral arthritis and active disease. Clin Rheumatol 35(12):3075\u20133079. https:\/\/doi.org\/10.1007\/s10067-016-3448-x","journal-title":"Clin Rheumatol"},{"issue":"1","key":"5968_CR40","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13075-020-02190-3","volume":"22","author":"M Jarlborg","year":"2020","unstructured":"Jarlborg M, Courvoisier DS, Lamacchia C, Martinez Prat L, Mahler M, Bentow C et al (2020) Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis. Arthritis Res Ther 22(1):105. https:\/\/doi.org\/10.1186\/s13075-020-02190-3","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"5968_CR41","doi-asserted-by":"publisher","first-page":"105068","DOI":"10.1016\/j.jbspin.2020.08.003","volume":"88","author":"X Romand","year":"2021","unstructured":"Romand X, Paclet MH, Courtier A, Nguyen MV, Wendling D, Berenbaum F et al (2021 Jan) (2021) Serum calprotectin is increased in early axial spondyloarthritis with sacroiliitis and objective signs of inflammation: results from the DESIR cohort. Joint Bone Spine 88(1):105068. https:\/\/doi.org\/10.1016\/j.jbspin.2020.08.003","journal-title":"Joint Bone Spine"},{"key":"5968_CR42","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nri3084","volume":"11","author":"J Neefjes","year":"2011","unstructured":"Neefjes J, Jongsma ML, Paul P, Bakke O (2011) Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol 11:823\u2013836. https:\/\/doi.org\/10.1038\/nri3084","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"5968_CR43","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3389\/fimmu.2019.00574","volume":"26","author":"NR Ziade","year":"2019","unstructured":"Ziade NR, Mallak I, Merheb G, Ghorra P, Baerlecken N, Witte T, Baraliakos X (2019) Added value of anti-CD74 autoantibodies in axial spondyloarthritis in a population with low HLA-B27 prevalence. Front Immunol 26(10):574. https:\/\/doi.org\/10.3389\/fimmu.2019.00574","journal-title":"Front Immunol"},{"issue":"1","key":"5968_CR44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.semarthrit.2020.12.002ls","volume":"51","author":"S Xu","year":"2021","unstructured":"Xu S, Zhang X, Chen Y, Ma Y, Deng J, Gao X, Guan S, Pan F (2021) Anti-CD74 antibodies in spondyloarthritis: a systematic review and meta-analysis. Semin Arthritis Rheum 51(1):7\u201314. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.12.002ls","journal-title":"Semin Arthritis Rheum"},{"key":"5968_CR45","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/art.40777","volume":"71","author":"E Riechers","year":"2019","unstructured":"Riechers E, Baerlecken N, Baraliakos X, Achilles-Mehr BK, Aries P, Bannert B et al (2019) Sensitivity and specificity of autoantibodies against CD74 in nonradiographic axial spondyloarthritis. Arthritis Rheumatol 71:729\u2013735","journal-title":"Arthritis Rheumatol"},{"issue":"50","key":"5968_CR46","doi-asserted-by":"publisher","first-page":"e23433","DOI":"10.1097\/MD.0000000000023433","volume":"99","author":"CJ Hu","year":"2020","unstructured":"Hu CJ, Li MT, Li X, Peng LY, Zhang SZ, Leng XM et al (2020) CD74 auto-antibodies display little clinical value in Chinese Han population with axial spondyloarthritis. Medicine (Baltimore) 99(50):e23433. https:\/\/doi.org\/10.1097\/MD.0000000000023433","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"5968_CR47","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13075-018-1535-x","volume":"20","author":"JJ de Winter","year":"2018","unstructured":"de Winter JJ, van de Sande MG, Baerlecken N, Inger B, Ramonda R, van der Heijde D et al (2018) Anti-CD74 antibodies have no diagnostic value in early axial spondyloarthritis: data from the spondyloarthritis caught early (SPACE) cohort. Arthritis Res Ther 20(1):38. https:\/\/doi.org\/10.1186\/s13075-018-1535-x","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"5968_CR48","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1002\/art.40175","volume":"69","author":"V Ranganathan","year":"2017","unstructured":"Ranganathan V, Ciccia F, Zeng F, Sari I, Guggino G, Muralitharan J et al (2017) Macrophage migration inhibitory factor induces inflammation and predicts spinal progression in ankylosing spondylitis. Arthritis Rheumatol 69(9):1796\u20131806. https:\/\/doi.org\/10.1002\/art.40175","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"5968_CR49","doi-asserted-by":"publisher","first-page":"e0134974","DOI":"10.1371\/journal.pone.0134974","volume":"10","author":"G Nocturne","year":"2015","unstructured":"Nocturne G, Pavy S, Boudaoud S, Seror R, Goupille P, Chanson P et al (2015) Increase in Dickkopf-1 serum level in recent spondyloarthritis. Data from the DESIR Cohort. PLoS One 10(8):e0134974. https:\/\/doi.org\/10.1371\/journal.pone.0134974","journal-title":"PLoS One"},{"issue":"5","key":"5968_CR50","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3899\/jrheum.170833","volume":"45","author":"MM Luchetti","year":"2018","unstructured":"Luchetti MM, Ciccia F, Avellini C, Benfaremo D, Guggino G, Farinelli A et al (2018) Sclerostin and antisclerostin antibody serum levels predict the presence of axial spondyloarthritis in patients with inflammatory bowel disease. J Rheumatol 45(5):630\u2013637. https:\/\/doi.org\/10.3899\/jrheum.170833","journal-title":"J Rheumatol"},{"issue":"12","key":"5968_CR51","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s00296-020-04708-z","volume":"40","author":"O Iaremenko","year":"2020","unstructured":"Iaremenko O, Shynkaruk I, Fedkov D, Iaremenko K, Petelytska L (2020) Bone turnover biomarkers, disease activity, and MRI changes of sacroiliac joints in patients with spondyloarthritis. Rheumatol Int 40(12):2057\u20132063. https:\/\/doi.org\/10.1007\/s00296-020-04708-z","journal-title":"Rheumatol Int"},{"issue":"2","key":"5968_CR52","first-page":"302","volume":"36","author":"F Genre","year":"2018","unstructured":"Genre F, Rueda-Gotor J, Remuzgo-Mart\u00ednez S, Corrales A, Ubilla B, Mijares V et al (2018) Implication of osteoprotegerin and sclerostin in axial spondyloarthritis cardiovascular disease: study of 163 Spanish patients. Clin Exp Rheumatol 36(2):302\u2013309","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"5968_CR53","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00223-019-00542-z.AS","volume":"105","author":"J Yang","year":"2019","unstructured":"Yang J, Xu S, Chen M, Yuan Y, Zhang X, Ma Y et al (2019) Serum sclerostin and bone morphogenetic protein-2 levels in patients with ankylosing spondylitis: a meta-analysis. Calcif Tissue Int 105(1):37\u201350. https:\/\/doi.org\/10.1007\/s00223-019-00542-z.AS","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"5968_CR54","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s10067-018-4356-z","volume":"38","author":"W Sun","year":"2019","unstructured":"Sun W, Tian L, Jiang L, Zhang S, Zhou M, Zhu J, Xue J (2019) Sclerostin rather than Dickkopf-1 is associated with mSASSS but not with disease activity score in patients with ankylosing spondylitis. Clin Rheumatol 38(4):989\u2013995. https:\/\/doi.org\/10.1007\/s10067-018-4356-z","journal-title":"Clin Rheumatol"},{"key":"5968_CR55","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cca.2018.03.010","volume":"481","author":"M Wu","year":"2018","unstructured":"Wu M, Chen M, Ma Y, Yang J, Han R, Yuan Y et al (2018) Dickkopf-1 in ankylosing spondylitis: review and meta-analysis. Clin Chim Acta 481:177\u2013183. https:\/\/doi.org\/10.1016\/j.cca.2018.03.010","journal-title":"Clin Chim Acta"},{"issue":"3","key":"5968_CR56","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/rheumatology\/keaa296","volume":"60","author":"E Descamps","year":"2021","unstructured":"Descamps E, Molto A, Borderie D, Lories R, Miceli-Richard C, Pons M et al (2021) Changes in bone formation regulator biomarkers in early axial spondyloarthritis. Rheumatology 60(3):1185\u20131194","journal-title":"Rheumatology"},{"issue":"12","key":"5968_CR57","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.3390\/jcm9123968","volume":"9","author":"JS Lee","year":"2020","unstructured":"Lee JS, Lee EJ, Lee JH, Hong SC, Lee CK, Yoo B et al (2020) Autoantibodies against protein phosphatase magnesium-dependent 1A as a biomarker for predicting radiographic progression in ankylosing spondylitis treated with anti-tumor necrosis factor agents. J Clin Med 9(12):3968. https:\/\/doi.org\/10.3390\/jcm9123968","journal-title":"J Clin Med"},{"issue":"1","key":"5968_CR58","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/03009742.2017.1287305","volume":"47","author":"HT Liao","year":"2018","unstructured":"Liao HT, Lin YF, Tsai CY, Chou TC (2018) Bone morphogenetic proteins and Dickkopf-1 in ankylosing spondylitis. Scand J Rheumatol 47(1):56\u201361. https:\/\/doi.org\/10.1080\/03009742.2017.1287305","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"5968_CR59","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.reuma.2016.04.013","volume":"13","author":"R Rubio Vargas","year":"2017","unstructured":"Rubio Vargas R, Melguizo Madrid E, Gonz\u00e1lez Rodr\u00edguez C, Navarro Sarabia F, Dominguez Quesada C, Ariza Ariza R, Navarro Comp\u00e1n V (2017) Association between serum dickkopf-1 levels and disease duration in axial spondyloarthritis. Reumatol Clin 13(4):197\u2013200. https:\/\/doi.org\/10.1016\/j.reuma.2016.04.013","journal-title":"Reumatol Clin"},{"issue":"12","key":"5968_CR60","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1111\/1756-185X.12791","volume":"20","author":"H Harman","year":"2017","unstructured":"Harman H, Tekeo\u011flu \u0130, G\u00fcrol G, Sa\u011f MS, Karake\u00e7e E, \u00c7\u0130ft\u00e7\u0130\u0130H, et al (2017) Comparison of fetuin-A and transforming growth factor beta 1 levels in patients with spondyloarthropathies and rheumatoid arthritis. Int J Rheum Dis 20(12):2020\u20132027. https:\/\/doi.org\/10.1111\/1756-185X.12791","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"5968_CR61","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1080\/08820139.2019.1567531","volume":"48","author":"M Chen","year":"2019","unstructured":"Chen M, Hu X, Wu M, Yang J, Han R, Ma Y et al (2019) Serum Levels of OPG, RANKL, and RANKL\/OPG ratio in patients with ankylosing spondylitis: a systematic review and meta-analysis. Immunol Invest 48(5):490\u2013504. https:\/\/doi.org\/10.1080\/08820139.2019.1567531","journal-title":"Immunol Invest"},{"issue":"1","key":"5968_CR62","doi-asserted-by":"publisher","first-page":"9636","DOI":"10.1038\/s41598-020-66816-x","volume":"10","author":"F Genre","year":"2020","unstructured":"Genre F, Rueda-Gotor J, Remuzgo-Mart\u00ednez S, Pulito-Cueto V, Corrales A, Mijares V et al (2020 Jun 15) (2020) Omentin: a biomarker of cardiovascular risk in individuals with axial spondyloarthritis. Sci Rep 10(1):9636. https:\/\/doi.org\/10.1038\/s41598-020-66816-x","journal-title":"Sci Rep"},{"key":"5968_CR63","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12865-018-0280-x","volume":"19","author":"Q Hu","year":"2018","unstructured":"Hu Q, Sun Y, Li Y, Shi H, Teng J, Liu H et al (2018) Anti-SIRT1 autoantibody is elevated in ankylosing spondylitis: a potential disease biomarker. BMC Immunol 19:38. https:\/\/doi.org\/10.1186\/s12865-018-0280-x","journal-title":"BMC Immunol"},{"issue":"5","key":"5968_CR64","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1136\/annrheumdis-2018-213815","volume":"78","author":"J Wang","year":"2019","unstructured":"Wang J, Wang C, Liang Y, Pan H, Jiang Z, Li Z et al (2019) Serum IgG N-glycans act as novel serum biomarkers of ankylosing spondylitis. Ann Rheum Dis 78(5):705\u2013707. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213815","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5968_CR65","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/cei.13374","volume":"199","author":"A Troldborg","year":"2020","unstructured":"Troldborg A, Thiel S, Mistegaard CE, Hansen A, Korsholm TL, Stengaard-Pedersen K, Loft AG (2020) Plasma levels of H- and L-ficolin are increased in axial spondyloarthritis: improvement of disease identification. Clin Exp Immunol 199(1):79\u201387. https:\/\/doi.org\/10.1111\/cei.13374","journal-title":"Clin Exp Immunol"},{"key":"5968_CR66","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cca.2019.11.028","volume":"503","author":"Y Sun","year":"2020","unstructured":"Sun Y, Ouyang B, Xie Q, Wang L, Zhu S, Jia Y (2020) Serum Deoxyribonuclease 1-like 3 is a potential biomarker for diagnosis of ankylosing spondylitis. Clin Chim Acta 503:197\u2013202. https:\/\/doi.org\/10.1016\/j.cca.2019.11.028","journal-title":"Clin Chim Acta"},{"key":"5968_CR67","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.3389\/fimmu.2020.02151","volume":"11","author":"J Xie","year":"2020","unstructured":"Xie J, Wang Z, Wang W (2020) Semaphorin 4D induces an imbalance of Th17\/Treg cells by activating the aryl hydrocarbon receptor in ankylosing spondylitis. Front Immunol 11:2151. https:\/\/doi.org\/10.3389\/fimmu.2020.02151","journal-title":"Front Immunol"},{"issue":"1","key":"5968_CR68","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jmii.2017.07.001","volume":"52","author":"HT Liao","year":"2017","unstructured":"Liao HT, Lin YF, Chou CT, Tsai C (2017) Semaphorin 3A in ankylosing spondylitis. J Microbiol Immunol Infect 52(1):151\u2013157. https:\/\/doi.org\/10.1016\/j.jmii.2017.07.001","journal-title":"J Microbiol Immunol Infect"},{"issue":"2","key":"5968_CR69","first-page":"313","volume":"35","author":"FM Perrotta","year":"2017","unstructured":"Perrotta FM, Ceccarelli F, Barbati C, Colasanti T, Montepaone M, Alessandri C et al (2017) Assessment of semaphorin 3A and its role in bone remodelling in a group of ankylosing spondylitis patients. Clin Exp Rheumatol 35(2):313\u2013316","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"5968_CR70","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12929-020-00634-1","volume":"27","author":"P Ruiz-Limon","year":"2020","unstructured":"Ruiz-Limon P, Ladehesa-Pineda ML, Castro-Villegas MDC, Abalos-Aguilera MDC, Lopez-Medina C, Lopez-Pedrera C et al (2020) Enhanced NETosis generation in radiographic axial spondyloarthritis: utility as biomarker for disease activity and anti-TNF-\u03b1 therapy effectiveness. J Biomed Sci 27(1):54. https:\/\/doi.org\/10.1186\/s12929-020-00634-1","journal-title":"J Biomed Sci"},{"issue":"6","key":"5968_CR71","doi-asserted-by":"publisher","first-page":"e22914","DOI":"10.1002\/jcla.22914","volume":"33","author":"MY Cao","year":"2019","unstructured":"Cao MY, Wang J, Gao XL, Hu YB (2019) Serum galectin-3 concentrations in patients with ankylosing spondylitis. J Clin Lab Anal 33(6):e22914. https:\/\/doi.org\/10.1002\/jcla.22914","journal-title":"J Clin Lab Anal"},{"issue":"5","key":"5968_CR72","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s10067-017-3938-5","volume":"37","author":"L Gupta","year":"2018","unstructured":"Gupta L, Bhattacharya S, Aggarwal A (2018) Tenascin-C, a biomarker of disease activity in early ankylosing spondylitis. Clin Rheumatol 37(5):1401\u20131405. https:\/\/doi.org\/10.1007\/s10067-017-3938-5","journal-title":"Clin Rheumatol"},{"issue":"11","key":"5968_CR73","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1007\/s00296-016-3536-x","volume":"36","author":"S Baspinar","year":"2016","unstructured":"Baspinar S, K\u0131rnap M, Basp\u0131nar O, Dizdar OS, Kocer D (2016) Serum prolidase level in ankylosing spondylitis: low serum levels as a new potential gold standard biomarker for disease activity. Rheumatol Int 36(11):1609\u20131616. https:\/\/doi.org\/10.1007\/s00296-016-3536-x","journal-title":"Rheumatol Int"},{"issue":"3","key":"5968_CR74","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s12031-015-0517-6","volume":"56","author":"IV Seoane","year":"2015","unstructured":"Seoane IV, Tomero E, Mart\u00ednez C, Garcia-Vicu\u00f1a R, Juarranz Y, Lamana A et al (2015) Vasoactive intestinal peptide in early spondyloarthritis: low serum levels as a potential biomarker for disease severity. Mol Neurosci 56(3):577\u2013584. https:\/\/doi.org\/10.1007\/s12031-015-0517-6","journal-title":"Mol Neurosci"},{"issue":"8","key":"5968_CR75","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1007\/s00296-018-4073-6","volume":"38","author":"DH Sohn","year":"2018","unstructured":"Sohn DH, Jeong H, Roh JS, Lee HN, Kim E, Koh JH, Lee SG (2018) Serum CCL11 level is associated with radiographic spinal damage in patients with ankylosing spondylitis. Rheumatol Int 38(8):1455\u20131464. https:\/\/doi.org\/10.1007\/s00296-018-4073-6","journal-title":"Rheumatol Int"},{"issue":"6","key":"5968_CR76","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jbspin.2015.10.011","volume":"83","author":"J Maillet","year":"2016","unstructured":"Maillet J, Ottaviani S, Tubach F, Roy C, Nicaise-Rolland P, Palazzo E (2016 Dec) Dieud\u00e9 P (2016) Anti-Saccharomyces cerevisiae antibodies (ASCA) in spondyloarthritis: prevalence and associated phenotype. Joint Bone Spine 83(6):665\u2013668. https:\/\/doi.org\/10.1016\/j.jbspin.2015.10.011","journal-title":"Joint Bone Spine"},{"issue":"1","key":"5968_CR77","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/cei.12089","volume":"173","author":"NS Lai","year":"2013","unstructured":"Lai NS, Yu HC, Chen HC, Yu CL, Huang HB, Lu MC (2013) Aberrant expresstion of microRNAs in T cells from patients with ankylosing spondylitis contributes to the immunopathogenesis. Clin Exp Immunol 173(1):47\u201357. https:\/\/doi.org\/10.1111\/cei.12089","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"5968_CR78","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00296-015-3397-8","volume":"36","author":"HL Munk","year":"2016","unstructured":"Munk HL, Gudmann NS, Christensen AF, Ejstrup L, Sorensen GL, Loft AG et al (2016) Cartilage collagen type II seromarker patterns in axial spondyloarthritis and psoriatic arthritis: associations with disease activity, smoking and HLA-B27. Rheumatol Int 36(4):541\u2013549. https:\/\/doi.org\/10.1007\/s00296-015-3397-8","journal-title":"Rheumatol Int"},{"key":"5968_CR79","doi-asserted-by":"publisher","first-page":"9101964","DOI":"10.1155\/2018\/9101964","volume":"2018","author":"FM Perrotta","year":"2018","unstructured":"Perrotta FM, Ceccarelli F, Barbati C, Colasanti T, De Socio A, Scriffignano S et al (2018) Serum sclerostin as a possible biomarker in ankylosing spondylitis: a case-control study. J Immunol Res 2018:9101964. https:\/\/doi.org\/10.1155\/2018\/9101964","journal-title":"J Immunol Res"},{"issue":"1","key":"5968_CR80","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12891-017-1425-4","volume":"18","author":"CC Niu","year":"2017","unstructured":"Niu CC, Lin SS, Yuan LJ, Chen LH, Yang CY, Chung AN et al (2017) Correlation of blood bone turnover biomarkers and Wnt signaling antagonists with AS, DISH, OPLL, and OYL. BMC Musculoskelet Disord 18(1):61. https:\/\/doi.org\/10.1186\/s12891-017-1425-4","journal-title":"BMC Musculoskelet Disord"},{"issue":"3","key":"5968_CR81","first-page":"415","volume":"35","author":"KY Kang","year":"2017","unstructured":"Kang KY, Jung JY, Hong YS, Ju JH, Park SH (2017) Positive correlation between inflammation on sacroiliac joint MRI and serum C-terminal telopeptide of type-I collagen in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis. Clin Exp Rheumatol 35(3):415\u2013422","journal-title":"Clin Exp Rheumatol"},{"key":"5968_CR82","doi-asserted-by":"publisher","first-page":"6537248","DOI":"10.1155\/2016\/6537248","volume":"2016","author":"C Wang","year":"2016","unstructured":"Wang C, Miao Y, Wu X, Huang Y, Sun M, Zhu Y et al (2016) Serum HMGB1 serves as a novel laboratory indicator reflecting disease activity and treatment response in ankylosing spondylitis patients. J Immunol Res 2016:6537248. https:\/\/doi.org\/10.1155\/2016\/6537248","journal-title":"J Immunol Res"},{"issue":"4","key":"5968_CR83","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1093\/rheumatology\/keaa460","volume":"60","author":"A Deminger","year":"2021","unstructured":"Deminger A, Klingberg E, Nurkkala M, Geijer M, Carlsten H, Jacobsson LTH (2021 Apr 6) Forsblad-d\u2019Elia H (2021) Elevated serum level of hepatocyte growth factor predicts development of new syndesmophytes in men with ankylosing spondylitis. Rheumatology (Oxford) 60(4):1804\u20131813. https:\/\/doi.org\/10.1093\/rheumatology\/keaa460","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"5968_CR84","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3109\/03009742.2016.1152399","volume":"45","author":"JI Gamez-Nava","year":"2016","unstructured":"Gamez-Nava JI, de la Cerda-Trujillo LF, Vazquez-Villegas ML, Cons-Molina F, Alcaraz-Lopez MF, Zavaleta-Mu\u00f1iz SA et al (2016) Association between bone turnover markers, clinical variables, spinal syndesmophytes and bone mineral density in Mexican patients with ankylosing spondylitis. Scand J Rheumatol 45(6):480\u2013490. https:\/\/doi.org\/10.3109\/03009742.2016.1152399","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"5968_CR85","first-page":"183","volume":"42","author":"A Kucukali Turkyilmaz","year":"2017","unstructured":"Kucukali Turkyilmaz A, Devrimsel G, Serdaroglu Beyazal M, Kirbas A, Cicek Y, Capkin E, Karkucak M, Kucukali GF, Turkyilmaz A et al (2017) The relationship between serum YKL-40 levels and arterial stiffness in patients with ankylosing spondylitis. Acta Reumatol Port 42(2):183\u2013190","journal-title":"Acta Reumatol Port"},{"issue":"1","key":"5968_CR86","doi-asserted-by":"publisher","first-page":"11218","DOI":"10.1038\/s41598-019-47502-z","volume":"9","author":"M Hu\u0161\u00e1kov\u00e1","year":"2019","unstructured":"Hu\u0161\u00e1kov\u00e1 M, Bay-Jensen AC, Forejtov\u00e1 \u0160, Zegzulkov\u00e1 K, Tom\u010d\u00edk M, Gregov\u00e1 M et al (2019) Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis. Sci Rep 9(1):11218. https:\/\/doi.org\/10.1038\/s41598-019-47502-z","journal-title":"Sci Rep"},{"issue":"10","key":"5968_CR87","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3389\/fimmu.2019.00384","volume":"5","author":"OC Kwon","year":"2019","unstructured":"Kwon OC, Lee EJ, Lee JY, Youn J, Kim TH, Hong S et al (2019) Prefoldin 5 and anti-prefoldin 5 antibodies as biomarkers for uveitis in ankylosing spondylitis. Front Immunol 5(10):384. https:\/\/doi.org\/10.3389\/fimmu.2019.00384","journal-title":"Front Immunol"},{"issue":"8","key":"5968_CR88","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1007\/s10067-020-04998-5","volume":"39","author":"J Liu","year":"2020","unstructured":"Liu J, Zhu Q, Han J, Zhang H, Li Y, Ma Y et al (2020) The IgG galactosylation ratio is higher in spondyloarthritis patients and associated with the MRI score. Clin Rheumatol 39(8):2317\u20132323. https:\/\/doi.org\/10.1007\/s10067-020-04998-5","journal-title":"Clin Rheumatol"},{"issue":"9","key":"5968_CR89","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1093\/rheumatology\/kez025","volume":"58","author":"J Rademacher","year":"2019","unstructured":"Rademacher J, Tietz LM, Le L, Hartl A, Hermann KA, Sieper J et al (2019) Added value of biomarkers compared with clinical parameters for the prediction of radiographic spinal progression in axial spondyloarthritis. Rheumatology (Oxford) 58(9):1556\u20131564. https:\/\/doi.org\/10.1093\/rheumatology\/kez025","journal-title":"Rheumatology (Oxford)"},{"key":"5968_CR90","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1136\/annrheumdis-2012-202177","volume":"73","author":"X Baraliakos","year":"2014","unstructured":"Baraliakos X, Baerlecken N, Witte T, Heldmann F, Braun J (2014) High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritis. Ann Rheum Dis 73:1079\u20131082. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202177","journal-title":"Ann Rheum Dis"},{"key":"5968_CR91","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.imlet.2016.09.003","volume":"179","author":"M Wang","year":"2016","unstructured":"Wang M, Zhou X, Zhang H, Liu R, Xu N (2016) Associations of the VEGF level, VEGF rs2010963 G\/C gene polymorphism and ankylosing spondylitis risk in a Chinese Han population. Immunol Lett 179:56\u201360. https:\/\/doi.org\/10.1016\/j.imlet.2016.09.003","journal-title":"Immunol Lett"},{"key":"5968_CR92","doi-asserted-by":"publisher","first-page":"204062232096506","DOI":"10.1177\/2040622320965067","volume":"11","author":"I Arias de la Rosa","year":"2020","unstructured":"Arias de la Rosa I, Font P, Escudero-Contreras A, L\u00f3pez-Montilla MD, P\u00e9rez-S\u00e1nchez C, \u00c1balos-Aguilera MC et al (2020) Complement component 3 as biomarker of disease activity and cardiometabolic risk factor in rheumatoid arthritis and spondyloarthritis. Ther Adv Chronic Dis 11:2040622320965067. https:\/\/doi.org\/10.1177\/2040622320965067","journal-title":"Ther Adv Chronic Dis"},{"issue":"7","key":"5968_CR93","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.reuma.2019.11.003","volume":"17","author":"RM Ferreira","year":"2021","unstructured":"Ferreira RM, Pimenta S, Bernardes M, Costa L (2021) Association of anti-saccharomyces cerevisiae antibodies with clinical phenotype in spondyloarthritis patients. Reumatol Clin 17(7):376\u2013379. https:\/\/doi.org\/10.1016\/j.reuma.2019.11.003 (S1699-258X(20)30005-X)","journal-title":"Reumatol Clin"},{"key":"5968_CR94","doi-asserted-by":"publisher","first-page":"4029584","DOI":"10.1155\/2017\/4029584","volume":"2017","author":"C Romero-S\u00e1nchez","year":"2017","unstructured":"Romero-S\u00e1nchez C, Bautista-Molano W, Parra V, De Avila J, Rueda JC, Bello-Gualtero JM et al (2017) Gastrointestinal symptoms and elevated levels of anti- Saccharomyces cerevisiae antibodies are associated with higher disease activity in colombian patients with spondyloarthritis. Int J Rheumatol 2017:4029584. https:\/\/doi.org\/10.1155\/2017\/4029584","journal-title":"Int J Rheumatol"},{"issue":"6","key":"5968_CR95","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.reuma.2017.11.013","volume":"15","author":"MJ Moreno Mart\u00ednez","year":"2019","unstructured":"Moreno Mart\u00ednez MJ, Moreno Ramos MJ, Linares Ferrando LF, Moreno Mart\u00ednez MJ et al (2019) Relationship between fecal calprotectin, anti-Saccharomyces cerevisiae antibodies and other markers of disease activity in patients with spondyloarthritis. Reumatol Clin (Engl Ed) 15(6):360\u2013362. https:\/\/doi.org\/10.1016\/j.reuma.2017.11.013","journal-title":"Reumatol Clin (Engl Ed)"},{"key":"5968_CR96","doi-asserted-by":"publisher","first-page":"504208","DOI":"10.1155\/2015\/504208","volume":"2015","author":"Q Lv","year":"2015","unstructured":"Lv Q, Li Q, Zhang P, Jiang Y, Wang X, Wei Q et al (2015) (2015) Disorders of microRNAs in peripheral blood mononuclear cells: as novel biomarkers of ankylosing spondylitis and provocative therapeutic targets. Biomed Res Int 2015:504208. https:\/\/doi.org\/10.1155\/2015\/504208","journal-title":"Biomed Res Int"},{"issue":"5","key":"5968_CR97","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s10067-015-3123-7","volume":"35","author":"MN Magrey","year":"2016","unstructured":"Magrey MN, Haqqi T, Abdul Haseeb A (2016) Identification of plasma microRNA expression profile in radiographic axial spondyloarthritis-a pilot study. Clin Rheumatol 35(5):1323\u20131327. https:\/\/doi.org\/10.1007\/s10067-015-3123-7","journal-title":"Clin Rheumatol"},{"issue":"9","key":"5968_CR98","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/BRS.0000000000001339","volume":"41","author":"BP Qian","year":"2016","unstructured":"Qian BP, Ji ML, Qiu Y, Wang B, Yu Y, Shi W, Luo YF (2016) Identification of serum miR-146a and miR-155 as novel noninvasive complementary biomarkers for ankylosing spondylitis. Spine (Phila Pa 1976) 41(9):735\u201342. https:\/\/doi.org\/10.1097\/BRS.0000000000001339","journal-title":"Spine (Phila Pa 1976)"},{"issue":"5","key":"5968_CR99","doi-asserted-by":"publisher","first-page":"955","DOI":"10.7754\/Clin.Lab.2017.161214","volume":"63","author":"J Huang","year":"2017","unstructured":"Huang J, Song G, Yin Z, Fu Z, Ye Z (2017) MiR-29a and messenger RNA expression of bone turnover markers in canonical Wnt pathway in patients with ankylosing spondylitis. Clin Lab 63(5):955\u2013960. https:\/\/doi.org\/10.7754\/Clin.Lab.2017.161214","journal-title":"Clin Lab"},{"issue":"9","key":"5968_CR100","doi-asserted-by":"publisher","first-page":"e0185323","DOI":"10.1371\/journal.pone.0185323","volume":"12","author":"K Prajzlerov\u00e1","year":"2017","unstructured":"Prajzlerov\u00e1 K, Grobeln\u00e1 K, Hu\u0161\u00e1kov\u00e1 M, Forejtov\u00e1 S, J\u00fcngel A, Gay S et al (2017) Association between circulating miRNAs and spinal involvement in patients with axial spondyloarthritis. PLoS ONE 12(9):e0185323. https:\/\/doi.org\/10.1371\/journal.pone.0185323","journal-title":"PLoS ONE"},{"issue":"5","key":"5968_CR101","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/hmg\/ddy00","volume":"27","author":"C Perez-Sanchez","year":"2018","unstructured":"Perez-Sanchez C, Font-Ugalde P, Ruiz-Limon P, Lopez-Pedrera C, Castro-Villegas MC, Abalos-Aguilera MC et al (2018) Circulating microRNAs as potential biomarkers of disease activity and structural damage in ankylosing spondylitis patients. Hum Mol Genet 27(5):875\u2013890. https:\/\/doi.org\/10.1093\/hmg\/ddy00","journal-title":"Hum Mol Genet"},{"issue":"16","key":"5968_CR102","doi-asserted-by":"publisher","first-page":"5106","DOI":"10.26355\/eurrev_201808_15704","volume":"22","author":"CL Zhang","year":"2018","unstructured":"Zhang CL, Li YC, Wu JW, Zhu BL (2018) Expression and function of peripheral blood miRNA16a in patients with ankylosing spondylitis. Eur Rev Med Pharmacol Sci 22(16):5106\u20135113. https:\/\/doi.org\/10.26355\/eurrev_201808_15704","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"5968_CR103","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/14397595.2018.1453277","volume":"29","author":"W Yang","year":"2019","unstructured":"Yang W, Yan X, Xia Q, Tao Q, Gan X, Zhang Y et al (2019) Predisposition of six well-characterized microRNAs to syndesmophytes among Chinese patients with ankylosing spondylitis. Mod Rheumatol 29(1):173\u2013180. https:\/\/doi.org\/10.1080\/14397595.2018.1453277","journal-title":"Mod Rheumatol"},{"issue":"5","key":"5968_CR104","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s10067-019-04509-1","volume":"38","author":"P Reyes-Loyola","year":"2019","unstructured":"Reyes-Loyola P, Rodr\u00edguez-Henr\u00edquez P, Ballinas-Verdugo MA, Amezcua-Castillo LM, Ju\u00e1rez-Vicu\u00f1a Y, Jim\u00e9nez-Rojas V et al (2019) Plasma let-7i, miR-16, and miR-221 levels as candidate biomarkers for the assessment of ankylosing spondylitis in Mexican patients na\u00efve to anti-TNF therapy. Clin Rheumatol 38(5):1367\u20131373. https:\/\/doi.org\/10.1007\/s10067-019-04509-1","journal-title":"Clin Rheumatol"},{"issue":"7","key":"5968_CR105","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/1756-185X.13563","volume":"22","author":"X Li","year":"2019","unstructured":"Li X, Lv Q, Tu L, Zhao M, Zhang P, Li Q et al (2019) Aberrant expression of microRNAs in peripheral blood mononuclear cells as candidate biomarkers in patients with axial spondyloarthritis. Int J Rheum Dis 22(7):1188\u20131195. https:\/\/doi.org\/10.1111\/1756-185X.13563","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"5968_CR106","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1177\/1753425919842932","volume":"25","author":"YC Zou","year":"2019","unstructured":"Zou YC, Gao YP, Yin HD, Liu G (2019) Serum miR-21 expression correlates with radiographic progression but also low bone mineral density in patients with ankylosing spondylitis: a cross-sectional study. Innate Immun 25(5):314\u2013321. https:\/\/doi.org\/10.1177\/1753425919842932","journal-title":"Innate Immun"},{"issue":"2","key":"5968_CR107","first-page":"620","volume":"25","author":"T Yildirim","year":"2021","unstructured":"Yildirim T, Yesilada E, Eren F, Apaydin H, Gulbay G (2021) Assessment of plasma microRNA potentials as a non-invasive biomarker in patients with axial spondyloarthropathy. Eur Rev Med Pharmacol Sci 25(2):620\u2013625","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"7","key":"5968_CR108","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/jcb.29896","volume":"122","author":"M Horita","year":"2021","unstructured":"Horita M, Farquharson C, Stephen LA (2021) The role of miR-29 family in disease. J Cell Biochem 122(7):696\u2013715. https:\/\/doi.org\/10.1002\/jcb.29896","journal-title":"J Cell Biochem"},{"key":"5968_CR109","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.imlet.2020.07.008","volume":"227","author":"SS Mortazavi-Jahromi","year":"2020","unstructured":"Mortazavi-Jahromi SS, Aslani M, Mirshafiey A (2020) A comprehensive review on miR-146a molecular mechanisms in a wide spectrum of immune and non-immune inflammatory diseases. Immunol Lett 227:8\u201327. https:\/\/doi.org\/10.1016\/j.imlet.2020.07.008","journal-title":"Immunol Lett"},{"key":"5968_CR110","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1002\/art.33503","volume":"64","author":"JD Reveille","year":"2009","unstructured":"Reveille JD, Hirsch R, Dillon CF, Carroll MD, Weisman MH (2009) The prevalence of HLA-B27 in the US: data from the US National Health and Nutrition Examination Survey. Arthritis Rheum 64:1407\u20131411","journal-title":"Arthritis Rheum"},{"key":"5968_CR111","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1007\/s10067-021-05679-7","volume":"40","author":"MC Hwang","year":"2021","unstructured":"Hwang MC, Ridley L, Reveille JD (2021) Ankylosing spondylitis risk factors: a systematic literature review. Clin Rheumatol 40:3079\u20133093. https:\/\/doi.org\/10.1007\/s10067-021-05679-7","journal-title":"Clin Rheumatol"},{"key":"5968_CR112","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1001\/jama.1977.03270510035017","volume":"237","author":"A Calin","year":"1977","unstructured":"Calin A, Porta J, Fries JF, Schurman DJ (1977) Clinical history as a screening test for ankylosing spondylitis. JAMA 237:2613\u20132614","journal-title":"JAMA"},{"key":"5968_CR113","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/art.21619","volume":"54","author":"M Rudwaleit","year":"2006","unstructured":"Rudwaleit M, Metter A, Listing J, Sieper J, Braun J (2006) Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum 54:569\u2013578","journal-title":"Arthritis Rheum"},{"key":"5968_CR114","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/ard.2008.101501","volume":"68","author":"J Seiper","year":"2009","unstructured":"Seiper J, van der Heijde D, Landewe R, Brandt J, Burgos-Vagas R, Collantes-Estevez E et al (2009) New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis 68:784\u2013788","journal-title":"Ann Rheum Dis"},{"key":"5968_CR115","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1148\/radiology.166.1.3336678","volume":"166","author":"MT Modic","year":"1988","unstructured":"Modic MT, Steinberg PM, Ross JS, Masaryk TJ, Carter JR (1988) Degenerative disk disease: assessment of changes in vertebral body marrow with MR imaging. Radiology 166:193\u2013199","journal-title":"Radiology"},{"key":"5968_CR116","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1007\/s00586-016-4459-7","volume":"25","author":"S Dudli","year":"2016","unstructured":"Dudli S, Fields AJ, Samartzis D, Karppinen J, Lotz JC (2016) Pathobiology of Modic changes. Eur Spine J 25:3723\u20133734","journal-title":"Eur Spine J"},{"key":"5968_CR117","doi-asserted-by":"publisher","first-page":"e000657","DOI":"10.1136\/rmdopen-2018-000657","volume":"4","author":"F de Bruin","year":"2018","unstructured":"de Bruin F, Treyvaud MO, Feydy A, de Hooge M, Pialat J-B, Dougados M et al (2018) (2018) Prevalence of degenerative changes and overlap with spondyloarthritis-associated lesions in the spine of patients from the DESIR cohort. RMD Open 4:e000657. https:\/\/doi.org\/10.1136\/rmdopen-2018-000657","journal-title":"RMD Open"},{"issue":"11","key":"5968_CR118","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.3899\/jrheum.100165","volume":"37","author":"C Nguyen","year":"2010","unstructured":"Nguyen C, Bendeddouche I, Sanchez K, Jousse M, Papelard A, Feydy A et al (2010) Assessment of ankylosing spondylitis criteria in patients with chronic low back pain and vertebral endplate Modic I signal changes. J Rheumatol 37(11):2334\u20132339","journal-title":"J Rheumatol"},{"issue":"7","key":"5968_CR119","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1002\/art.22985","volume":"57","author":"F Rannou","year":"2007","unstructured":"Rannou F, Ouanes W, Boutron I, Lovisi B, Fayad F, Mace Y et al (2007) High-sensitivity C-reactive protein in chronic low back pain with vertebral end-plate Modic signal changes. Arthritis Rheum 57(7):1311\u20131315. https:\/\/doi.org\/10.1002\/art.22985","journal-title":"Arthritis Rheum"},{"key":"5968_CR120","doi-asserted-by":"publisher","unstructured":"Dudli S, Ballatori A, Bay-Jensen AC, McCormick ZL, O\u2019Neill CW, Demir-Deviren S, et al (2020) Serum biomarkers for connective tissue and basement membrane remodeling are associated with vertebral endplate bone marrow lesions as seen on MRI (Modic\u00a0Changes). Int J Mol Sci 21(11): 3791.\u00a0Published online 2020 May 27. https:\/\/doi.org\/10.3390\/ijms21113791","DOI":"10.3390\/ijms21113791"},{"key":"5968_CR121","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1093\/rheumatology\/kez095","volume":"58","author":"M van Lunteren","year":"2019","unstructured":"van Lunteren M, van der Heijde D, Sepriano A, Berg IJ, Dougados M, Gossec L et al (2019) Is a positive family history of spondyloarthritis relevant for diagnosing axial spondyloarthritis once HLA-B27 status is known? Rheumatology (Oxford) 58:1649\u20131654. https:\/\/doi.org\/10.1093\/rheumatology\/kez095","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"5968_CR122","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1093\/rheumatology\/kez125","volume":"58","author":"J Braun","year":"2019","unstructured":"Braun J (2019) Using combinations of biomarkers to understand inflammation and bone formation in axial spondyloarthritis - is anything better than CRP? Rheumatology (Oxford) 58(9):1517\u20131519. https:\/\/doi.org\/10.1093\/rheumatology\/kez125","journal-title":"Rheumatology (Oxford)"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05968-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-05968-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05968-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T03:10:39Z","timestamp":1645758639000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-05968-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,21]]},"references-count":122,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["5968"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-05968-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,21]]},"assertion":[{"value":"7 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}